Modern microbiome studies rely heavily on Next-Generation Sequencing (NGS) technologies. These approaches allow researchers to examine complex microbial communities with exceptional resolution. However, despite their strengths, microbiome workflows are prone to a range of technical biases that can affect both data accuracy and reproducibility. One of the most important—yet frequently overlooked—sources of error occurs during DNA extraction, particularly due to a phenomenon known as lysis bias.
The challenge of lysis bias in DNA extraction
Lysis bias arises when microorganisms are broken open with differing efficiencies, leading to certain taxa being either underrepresented or overrepresented in the resulting dataset. The ability of a cell to release its DNA depends largely on the structure of its cell envelope. Mammalian cells, which are surrounded only by a lipid membrane, are relatively easy to disrupt. In contrast, Gram-positive bacteria have thick, highly organised peptidoglycan walls that require more intense treatment to achieve effective lysis. Zymo Research describes this resistance as “cell wall recalcitrance,” a concept used to classify organisms based on how difficult they are to lyse. As this recalcitrance increases, so does the likelihood of incomplete lysis and the introduction of bias into the data.
Real-world evidence of bias in microbiome analysis
An illustrative example of microbiome bias was reported in a 2014 Science News article titled “Here’s the Poop on Getting Your Gut Microbiome Analysed.” In this case, identical faecal samples were submitted to two separate microbiome testing services, yet produced strikingly different results. The American Gut Project identified Bacteroidetes—Gram-negative bacteria—as the dominant group. Meanwhile, µBiome’s analysis indicated that Firmicutes, which are largely Gram-positive, were most abundant. A likely explanation for this discrepancy is variation in lysis efficiency. In particular, insufficient breakdown of Gram-positive cells may have caused Firmicutes to appear underrepresented in the American Gut dataset.
Identifying lysis issues before sequencing starts
Indicators of lysis-related problems can often be spotted even before sequencing is performed. For example, when working with a mock microbial community standard, a typical DNA yield might be approximately 2 micrograms from 75 microliters of sample. If the extracted DNA quantity is significantly lower than expected, this should prompt closer examination. If downstream sequencing results also show both reduced yield and an overrepresentation of Gram-negative organisms, it strongly suggests inadequate lysis of more resilient microbes. On the other hand, if DNA yield is low but no clear taxonomic bias is observed, other factors—such as DNA purification efficiency, sample loss, or inaccuracies in quantification—should be investigated.
The importance of routine standards and yield monitoring
To maintain reliable results, it is considered best practice to include a reference standard on a routine basis, ideally alongside each batch of samples. Tracking DNA yields across multiple runs helps detect inconsistencies early, such as issues with reagents or protocol deviations. A sudden drop in yield under otherwise identical conditions and measurement methods is a clear indication that something within the workflow requires attention and correction.
Amplification bias and GC content effects
Beyond the extraction step, amplification bias is another major source of variability in microbiome data. Often referred to as GC bias, this issue arises from differences in guanine-cytosine content between microbial genomes. Because GC base pairs form stronger bonds than adenine-thymine pairs, regions with high GC content can be more difficult to denature during PCR. As a result, workflows with suboptimal PCR settings—or those requiring excessive amplification—may introduce distortions in representation. Although Firmicutes typically have lower GC content, making them easier to amplify, this characteristic may also lead to their apparent overrepresentation under biased PCR conditions, as possibly observed in the µBiome findings.
Why standardised controls are essential in microbiome research
Without appropriate controls, it is not possible to fully determine which biases are affecting a dataset or how strongly they influence the final microbial profile. However, by analysing the same sample across multiple platforms, the Science News example highlights the critical role of standardised controls in microbiome research. Using a well-characterised reference material—rather than variable biological samples such as faeces—enables researchers to detect bias, validate workflows, and resolve issues before analysing valuable experimental samples. Incorporating such controls is therefore essential for generating data that is both consistent and reproducible.
How Zymo Research Microbial Standards support accurate microbiome analysis
Zymo Research’s microbial standards are specifically developed to meet the need for reliable and well-characterised reference materials in microbiome research. These standards contain defined microbial compositions with known taxonomic profiles and controlled quantities, enabling objective assessment of DNA extraction efficiency, amplification bias, and overall workflow performance. By including organisms with varying cell wall properties and lysis sensitivities, these standards help identify biases related to cell wall recalcitrance that might otherwise remain undetected. When used routinely as internal controls, they allow researchers to benchmark methods, monitor consistency over time, and detect sources of technical variation before impacting experimental samples. Consequently, Zymo Research’s microbial standards provide a practical and robust foundation for improving data quality, reproducibility, and confidence in microbiome sequencing studies.
Featured supplier
Zymo Research
Zymo Research is a leader in molecular biology, offering a comprehensive range of products for DNA, RNA, and epigenetics research. Established in California in 1994, the company is renowned for its high-quality nucleic acid purification technologies, including kits and reagents for DNA and RNA clean-up, isolation, and sequencing. Zymo is also a pioneer in epigenetics, with products for DNA methylation analysis, chromatin analysis, and NGS library preparation. Each product is designed to be simple to use, reliable, and available at competitive prices, making them ideal for both academic and biopharmaceutical research.